L. Mirabello, R. J. Troisi, and S. A. Savage, Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program, Cancer, vol.115, issue.7, pp.1531-1574, 2009.

C. C. Chen and L. F. Lau, Functions and mechanisms of action of CCN matricellular proteins, Int J Biochem Cell Biol, vol.41, issue.4, pp.771-83, 2009.

L. F. Lau, CCN1/CYR61: the very model of a modern matricellular protein, Cell Mol Life Sci, vol.68, pp.3149-63, 2011.

N. Chen, S. J. Leu, V. Todorovic, S. C. Lam, and L. F. Lau, Identification of a novel integrin alphavbeta3 binding site in CCN1 (CYR61) critical for proangiogenic activities in vascular endothelial cells, J Biol Chem, vol.279, issue.42, pp.44166-76, 2004.

S. J. Leu, S. C. Lam, and L. F. Lau, Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells, J Biol Chem, vol.277, issue.48, pp.46248-55, 2002.

A. M. Babic, M. L. Kireeva, T. V. Kolesnikova, and L. F. Lau, CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth, Proc Natl Acad Sci, vol.95, issue.11, pp.6355-60, 1998.

J. A. Menéndez, I. Mehmi, D. W. Griggs, and R. Lupu, The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives, Endocr Relat Cancer, vol.10, issue.2, pp.141-52, 2003.

W. G. Jiang, G. Watkins, O. Fodstad, D. , A. Mokbel et al., Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer, Endocr Relat Cancer, vol.11, issue.4, pp.781-91, 2004.

Z. J. Sun, Y. Wang, Z. Cai, P. P. Chen, X. J. Tong et al., Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells, Br J Cancer, vol.99, issue.10, pp.1656-67, 2008.

D. Jeong, S. Heo, S. Ahn, T. Lee, S. Park et al., Cyr61 expression is associated with prognosis in patients with colorectal cancer, BMC Cancer, vol.14, p.164, 2014.

N. Habel, M. Vilalta, O. Bawa, P. Opolon, J. Blanco et al., Cyr61 silencing reduces vascularization and dissemination of osteosarcoma tumors, Oncogene, vol.34, issue.24, pp.3207-3220, 2015.

O. Fromigue, Z. Hamidouche, P. Vaudin, F. Lecanda, A. Patino et al., CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis, J Bone Miner Res, vol.26, issue.7, pp.1533-1575, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00626140

A. A. Sabile, M. J. Arlt, R. Muff, B. Bode, B. Langsam et al., Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice, J Bone Miner Res, vol.27, issue.1, pp.58-67, 2012.

J. P. Thiery and J. P. Sleeman, Complex networks orchestrate epithelialmesenchymal transitions, Nat Rev Mol Cell Biol, vol.7, issue.2, pp.131-173, 2006.

M. A. Nieto, R. Y. Huang, R. A. Jackson, J. P. Thiery, and . Emt, Cell, vol.166, issue.1, pp.21-45, 2016.

S. Lamouille, J. Xu, and R. Derynck, Molecular mechanisms of epithelialmesenchymal transition, Nat Rev Mol Cell Biol, vol.15, issue.3, pp.178-96, 2014.

G. Nakajima, A. Patino-garcia, S. Bruheim, Y. Xi, S. Julian et al., CDH11 expression is associated with survival in patients with osteosarcoma, Cancer Genomics Proteomics, vol.5, issue.1, pp.37-42, 2008.

Y. Shang, Z. Li, H. Li, H. Xia, and Z. Lin, TIM-3 expression in human osteosarcoma: correlation with the expression of epithelial-mesenchymal transition-specific biomarkers, Oncol Lett, vol.6, issue.2, pp.490-494, 2013.

Y. Jian, C. Chen, B. Li, and X. Tian, Delocalized Claudin-1 promotes metastasis of human osteosarcoma cells, Biochem Biophys Res Commun, vol.466, issue.3, pp.356-61, 2015.

H. Yang, Y. Zhang, Z. Zhou, X. Jiang, and A. Shen, Transcription factor Snai1-1 induces osteosarcoma invasion and metastasis by inhibiting E-cadherin expression, Oncol Lett, vol.8, issue.1, pp.193-200, 2014.

Y. Niinaka, K. Harada, M. Fujimuro, M. Oda, A. Haga et al., Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis, Cancer Res, vol.70, issue.22, pp.9483-93, 2010.

N. Sévère, F. X. Dieudonné, C. Marty, D. Modrowski, A. Patiño-garcía et al., Targeting the E3 ubiquitin casitas B-lineage lymphoma decreases osteosarcoma cell growth and survival and reduces tumorigenesis, J Bone Miner Res, vol.27, issue.10, pp.2108-2125, 2012.

O. Fromigué, Z. Hamidouche, and P. J. Marie, Blockade of the RhoA-JNK-c-JunMMP2 cascade by atorvastatin reduces osteosarcoma cell invasion, J Biol Chem, vol.283, issue.45, pp.30549-56, 2008.

U. D. Kahlert, J. V. Joseph, and F. Kruyt, EMT-and MET-related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities, Mol Oncol, vol.11, issue.7, pp.860-77, 2017.

I. Haque, S. Mehta, M. Majumder, K. Dhar, A. De et al., Cyr61/CCN1 signaling is critical for epithelialmesenchymal transition and stemness and promotes pancreatic carcinogenesis, Mol Cancer, vol.10, issue.8, 2011.
DOI : 10.1186/1476-4598-10-8

URL : https://molecular-cancer.biomedcentral.com/track/pdf/10.1186/1476-4598-10-8

Y. Liu, Y. D. Zhou, Y. L. Xiao, M. H. Li, Y. Wang et al., Cyr61/ CCN1 overexpression induces epithelial-mesenchymal transition leading to laryngeal tumor invasion and metastasis and poor prognosis, Asian Pac J Cancer Prev, vol.16, issue.7, pp.2659-64, 2015.
DOI : 10.7314/apjcp.2015.16.7.2659

URL : http://www.ndsl.kr/soc_img/society/apocp/POCPA9/2015/v16n7/POCPA9_2015_v16n7_2659.pdf

M. T. Lin, C. Y. Zuon, C. C. Chang, S. T. Chen, C. P. Chen et al., Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/cyclooxygenase-2 signaling pathway, Clin Cancer Res, vol.11, issue.16, pp.5809-5829, 2005.

C. H. Hou, F. L. Lin, S. M. Hou, and J. F. Liu, Cyr61 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/ TWIST-1 signaling pathway, Mol Cancer, vol.13, p.236, 2014.

T. W. Tan, W. H. Yang, Y. T. Lin, S. F. Hsu, T. M. Li et al., Cyr61 increases migration and MMP-13 expression via alphavbeta3 integrin, FAK, ERK and AP-1-dependent pathway in human chondrosarcoma cells, Carcinogenesis, vol.30, issue.2, pp.258-68, 2009.
DOI : 10.1093/carcin/bgn284

URL : https://academic.oup.com/carcin/article-pdf/30/2/258/17287138/bgn284.pdf

L. F. Lau, Cell surface receptors for CCN proteins, J Cell Commun Signal, vol.10, issue.2, pp.121-128, 2016.
DOI : 10.1007/s12079-016-0324-z

URL : http://europepmc.org/articles/pmc4882306?pdf=render

J. L. Su, J. Chiou, C. H. Tang, M. Zhao, C. H. Tsai et al., CYR61 regulates BMP-2-dependent osteoblast differentiation through the {alpha}v{beta}3 integrin/integrin-linked kinase/ ERK pathway, J Biol Chem, vol.285, issue.41, pp.31325-31361, 2010.
DOI : 10.1074/jbc.m109.087122

URL : http://www.jbc.org/content/285/41/31325.full.pdf

T. D. Blalock, D. J. Gibson, M. R. Duncan, S. S. Tuli, G. R. Grotendorst et al., A connective tissue growth factor signaling receptor in corneal fibroblasts, Invest Ophthalmol Vis Sci, vol.53, issue.7, pp.3387-94, 2012.

K. E. Govoni, D. J. Baylink, and S. Mohan, The multi-functional role of insulin-like growth factor binding proteins in bone, Pediatr Nephrol, vol.20, issue.3, pp.261-269, 2005.

W. Zumkeller, O. Groth, and J. Commentz, Regulation of insulin-like growth factors and IGF-binding proteins in bone tumours, Growth Regul, vol.6, issue.1, pp.10-15, 1996.

J. Liang, B. Li, L. Yuan, and Z. Ye, Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: a meta-analysis, Onco Targets Ther, vol.8, pp.1949-55, 2015.

Y. H. Wang, X. D. Han, Y. Qiu, J. Xiong, Y. Yu et al., Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma, J Surg Oncol, vol.105, issue.3, pp.235-278, 2012.

N. D. Ebelt and M. A. Cantrell, Van Den Berg CL. C-Jun N-terminal kinases mediate a wide range of targets in the metastatic Cascade, Genes Cancer, vol.4, issue.9, pp.378-87, 2013.

C. Khanna, X. Wan, S. Bose, R. Cassaday, O. Olomu et al., The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis, Nat Med, vol.10, issue.2, pp.182-188, 2004.

A. J. Chou, D. S. Geller, and R. Gorlick, Therapy for osteosarcoma: where do we go from here?, Paediatr Drugs, vol.10, issue.5, pp.315-342, 2008.
DOI : 10.2165/00148581-200810050-00005

. Habel, BMC Cancer, vol.19, p.62, 2019.

E. A. Kolb, R. Gorlick, R. Lock, H. Carol, C. L. Morton et al., Initial testing (stage 1) of the IGF-1 receptor inhibitor BMS-754807 by the pediatric preclinical testing program, Pediatr Blood Cancer, vol.56, issue.4, pp.595-603, 2011.

P. J. Messerschmitt, A. N. Rettew, R. E. Brookover, R. M. Garcia, P. J. Getty et al., Specific tyrosine kinase inhibitors regulate human osteosarcoma cells in vitro, Clin Orthop Relat Res, vol.466, issue.9, pp.2168-75, 2008.

G. A. Luther, J. Lamplot, X. Chen, R. Rames, E. R. Wagner et al., IGFBP5 domains exert distinct inhibitory effects on the tumorigenicity and metastasis of human osteosarcoma, Cancer Lett, vol.336, issue.1, pp.222-252, 2013.

G. Chen, T. Fang, Z. Huang, Y. Qi, S. Du et al., MicroRNA-133a inhibits osteosarcoma cells proliferation and invasion via targeting IGF-1R, Cell Physiol Biochem, vol.38, issue.2, pp.598-608, 2016.

P. M. Anderson, S. S. Bielack, R. G. Gorlick, K. Skubitz, N. C. Daw et al., A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma, Pediatr Blood Cancer, vol.63, issue.10, pp.1761-70, 2016.

A. S. Pappo, G. Vassal, J. J. Crowley, V. Bolejack, P. C. Hogendoorn et al., A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a sarcoma Alliance for research through collaboration study, Cancer, vol.120, issue.16, pp.2448-56, 2014.

R. Bagatell, C. E. Herzog, T. M. Trippett, J. F. Grippo, G. Cirrincione-dall et al., Pharmacokinetically guided phase 1 trial of the IGF-1 receptor antagonist RG1507 in children with recurrent or refractory solid tumors, Clin Cancer Res, vol.17, issue.3, pp.611-620, 2011.

A. N. Rettew, P. J. Getty, and E. M. Greenfield, Receptor tyrosine kinases in osteosarcoma: not just the usual suspects, Adv Exp Med Biol, vol.804, pp.47-66, 2014.

Y. Zhou, T. Huang, A. S. Cheng, J. Yu, W. Kang et al., The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis, Int J Mol Sci, vol.17, issue.1, pp.138-52, 2016.

C. Bouvier, N. Macagno, Q. Nguyen, A. Loundou, C. Jiguet-jiglaire et al., Prognostic value of the hippo pathway transcriptional coactivators YAP/TAZ and ?1-integrin in conventional osteosarcoma, Oncotarget, vol.7, issue.40, pp.64702-64712, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01482390

S. Shen, K. Huang, Y. Wu, Y. Ma, J. Wang et al., A miR-135b-TAZ positive feedback loop promotes epithelial-mesenchymal transition (EMT) and tumorigenesis in osteosarcoma, Cancer Lett, vol.407, pp.32-44, 2017.

H. Zhang, H. A. Pasolli, and E. Fuchs, Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin, Proc Natl Acad Sci, vol.108, issue.6, pp.2270-2275, 2011.

A. J. Saraf, J. M. Fenger, and R. D. Roberts, Osteosarcoma: accelerating Progress makes for a hopeful future, Front Oncol, vol.26, issue.8, p.4, 2018.

G. Zhao, B. L. Huang, D. Rigueur, W. Wang, C. Bhoot et al., CYR61/CCN1 regulates Sclerostin levels and bone maintenance, J Bone Miner Res, vol.33, issue.6, pp.1076-89, 2018.
DOI : 10.1002/jbmr.3394

Z. Hamidouche, E. Haÿ, P. Vaudin, P. Charbord, R. Schüle et al., FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression, FASEB J, vol.22, issue.11, pp.3813-3835, 2008.
DOI : 10.1096/fj.08-106302

H. Schayek, K. Haugk, S. Sun, L. D. True, S. R. Plymate et al., Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner, Clin Cancer Res, vol.15, issue.5, pp.1558-65, 2009.